2024

• Arunogiri, S., Morley, K. (2024). Commentary on Aubin et al.: Could combination medication approaches target mental health comorbidity in the context of alcohol use disorder? Addiction, 119(7), 1224-1225. [More Information]
• Higginbotham, B., Perez, J., Louie, E., Haber, P., Lubman, D., Arunogiri, S., Chatterton, M., Morley, K. (2024). Economic evaluations of alcohol pharmacotherapy: Systematic review of economic evaluations of pharmacotherapy for the treatment of alcohol use disorder. Australian and New Zealand Journal of Psychiatry, 58(2), 117-133. [More Information]
• Conigrave, J., Lee, K., Dobbins, T., Wilson, S., Padarian Campusano, J., Ivers, R., Morley, K., Haber, P., Vnuk, J., Marshall, K., Conigrave, K. (2024). No improvement in AUDIT-C screening and brief intervention rates among wait-list controls following support of Aboriginal Community Controlled Health Services: evidence from a cluster randomised trial. BMC Health Services Research, 24(1). [More Information]
• Sangchooli, A., Potvin, S., Ahmadi, P., Bach, P., Baldacchino, A., Beck, A., Brady, K., Brewer, J., Childress, A., Courtney, K., Morley, K., et al (2024). Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity: A Systematic Review. JAMA Psychiatry, , 5483. [More Information]
• Hurzeler, T., Logge, W., Watt, J., DeMayo, M., Suraev, A., McGregor, I., Haber, P., Morley, K. (2024). The neurobehavioural effects of cannabidiol in alcohol use disorder: Study protocol for a double-blind, randomised, cross over, placebo-controlled trial. Contemporary Clinical Trials Communications, 41, 101341. [More Information]

2023

• Sullivan, A., Ridley, N., Monds, L., Logberger, W., Hurzeler, T., Morley, K. (2023). Assessing the validity of the Wechsler Adult Intelligence Scale (WAIS-IV) in predicting completion in a long-term residential rehabilitation for substance use problems. Applied Neuropsychology. Adult, 30(5), 561-566. [More Information]
• Adams, C., Perry, N., Conigrave, J., Hurzeler, T., Stevens, J., Yacou Dunbar, K., Sweeney, A., Lee, K., Sutherland, G., Haber, P., Morley, K. (2023). Central markers of neuroinflammation in alcohol use disorder: A meta-analysis of neuroimaging, cerebral spinal fluid, and postmortem studies. Alcoholism: Clinical and Experimental Research, 47(2), 197-208. [More Information]
• Louie, E., Giannopoulos, V., Uribe Guajardo, M., Wood, K., Teesson, M., Childs, S., Baillie, A., Haber, P., Morley, K. (2023). Geographical variation in implementation of the Pathways to Comorbidity Care program in Australian drug and alcohol services. JBI Database of Systematic Reviews and Implementation Reports, 21(2), 186-193. [More Information]
• Mason, A., Riordan, B., Morley, K., Winter, T., Haber, P., Scarf, D. (2023). High Risk or Risky Highs: Understanding the Links Between Alcohol and Cannabis Use on the Transition From Suicidal Ideation to Attempts in Australian Men. Archives of Suicide Research. [More Information]
• Logge, W., Hurzeler, T., Arunogiri, S., Towers, E., Baillie, A., Haber, P., Morley, K. (2023). Hypothalamic-pituitary-adrenocortical response in alcohol-dependent patients during baclofen treatment and association with clinical outcome: Preliminary results. Alcohol, 112, 25-29. [More Information]
• Logberger, W., Morley, K., Haber, P., Baillie, A. (2023). Impaired Decision-Making and Skin Conductance Responses Are Associated with Reward and Punishment Sensitivity in Individuals with Severe Alcohol Use Disorder. Neuropsychobiology, 82(2), 117-129. [More Information]
• Morley, K., Peruch, S., Adams, C., Towers, E., Tremonti, C., Watt, J., Jamshidi, N., Haber, P. (2023). N acetylcysteine in the treatment of alcohol use disorder: a randomized, double-blind, placebo-controlled trial. Alcohol and Alcoholism, 58(5), 553-560. [More Information]
• Logberger, W., Baillie, A., Haber, P., Towers, E., Riordan, B., Morley, K. (2023). Sex differences in the interrelations between stress, craving and alcohol consumption across individuals and time during baclofen treatment for alcohol dependence. Addictive Behaviors, 136. [More Information]
• Dali, G., Logge, W., Riordan, B., Conner, T., Manning, V., Millan, E., McNally, G., Haber, P., Morley, K. (2023). The role of impulsivity in the relationship between affect and alcohol consumption in young adults. Alcohol: Clinical and Experimental Research, 47(11), 2161-2168. [More Information]

2022

• Josifovski, N., Shand, F., Morley, K., Chia, J., Henshaw, R., Petrie, K., Reda, B., Li, E., Theobald, A., Onie, S., Haber, P., et al (2022). A pilot study of a text message and online brief contact intervention following self-harm or a suicide attempt: A mixed methods evaluation. General Hospital Psychiatry, 76, 2023-02-01 00:00:00. [More Information]
• Merrick, T., Louie, E., Cleary, M., Molloy, L., Baillie, A., Haber, P., Morley, K. (2022). A systematic review of the perceptions and attitudes of mental health nurses towards alcohol and other drug use in mental health clients. International Journal of Mental Health Nursing, 31(6), 1373-1389. [More Information]
• Maddern, X., Walker, L., Campbell, E., Arunogiri, S., Haber, P., Morley, K., Manning, V., Millan, E., McNally, G., Lubman, D., et al (2022). Can we enhance the clinical efficacy of cognitive and psychological approaches to treat substance use disorders through understanding their neurobiological mechanisms? Neuroscience and Biobehavioral Reviews, 142. [More Information]
• Morley, K., Logberger, W., Riordan, B., Brannon, S., Haber, P., Conner, T. (2022). Daily experiences of hangover severity and food consumption in young adults. British Journal of Health Psychology, 27(2), 468-483. [More Information]
• Logge, W., Morley, K., Haber, P. (2022). GABAB Receptors and Alcohol Use Disorders: Clinical Studies. Current Topics in Behavioral Neurosciences, 52, 195-212. [More Information]
• Louie, E., Giannopoulos, V., Baillie, A., Uribe Guajardo, M., Wood, K., Teesson, M., Haber, P., Morley, K. (2022). Relationship between clinician-level attributes and implementation outcomes from the Pathways to Comorbidity Care training program. BMC Medical Education, 22(1). [More Information]
• Morley, K., Louie, E., Hurzeler, T., Baillie, A., Dore, G., Phung, N., Haber, P. (2022). Sex as a Potential Moderator for Baclofen Response in the Treatment of Alcohol Dependence. Frontiers in Global Women's Health, 3(807269), 1-7. [More Information]
• Chitty, K., Cvejic, R., Heintze, T., Srasuebkul, P., Morley, K., Dawson, A., Carter, G., Dinh, M., Buckley, N., Trollor, J. (2022). The Association between Problematic Use of Alcohol and Drugs and Repeat Self-Harm and Suicidal Ideation: Insights from a Population-Based Administrative Health Data Set. Crisis-the Journal of Crisis Intervention and Suicide Prevention. [More Information]
• Uribe Guajardo, M., Baillie, A., Louie, E., Giannopoulos, V., Wood, K., Riordan, B., Haber, P., Morley, K. (2022). The evaluation of the role of technology in the pathways to comorbidity care implementation project to improve management of comorbid substance use and mental disorders. Journal of Multimorbidity and Comorbidity, 12. [More Information]

2021

• Mason, A., Jang, K., Morley, K., Scarf, D., Collings, S., Riordan, B. (2021). A Content Analysis of Reddit Users' Perspectives on Reasons for Not following through with a Suicide Attempt. CyberPsychology, Behavior, and Social Networking, 24(10), 642-647. [More Information]
• Louie, E., Barrett, E., Baillie, A., Haber, P., Morley, K. (2021). A systematic review of evidence-based practice implementation in drug and alcohol settings: applying the consolidated framework for implementation research framework. Implementation Science, 16(1), 22-1-22-29. [More Information]
• Giannopoulos, V., Morley, K., Haber, P. (2021). Alcohol Use and misuse during the COVID-19 pandemic. Medicine Today, 22(4), 14-20.
• Winter, D., Geiger, B., Morley, K., Conigrave, J., Haber, P., Riordan, B. (2021). Are bottle shops using Twitter to increase advertising or encourage drinking during COVID-19? Australian and New Zealand Journal of Public Health, 45(4), 391-393. [More Information]
• Logberger, W., Morris, R., Baillie, A., Haber, P., Morley, K. (2021). Baclofen attenuates fMRI alcohol cue reactivity in treatment-seeking alcohol dependent individuals. Psychopharmacology, 238(5), 1291-1302. [More Information]
• Louie, E., Giannopoulos, V., Baillie, A., Uribe Guajardo, M., Wood, K., Teesson, M., Childs, S., Rogers, K., Haber, P., Morley, K. (2021). Barriers and Facilitators to the Implementation of the Pathways to Comorbidity Care (PCC) Training Package for the Management of Comorbid Mental Disorders in Drug and Alcohol Settings. frontiers in health services, 1, 785391. [More Information]
• Morley, K. (2021). Commentary on Donoghue: Low prescribing rates of pharmacotherapy for alcohol use disorder limit potential public health impact. Addiction, 116(11), 3027-3028. [More Information]
• Morley, K., Logberger, W., Fraser, I., Morris, R., Baillie, A., Haber, P. (2021). High-dose baclofen attenuates insula activation during anticipatory anxiety in treatment-seeking alcohol dependant individuals: Preliminary findings from a pharmaco-fMRI study. European Neuropsychopharmacology, 46, 28-36. [More Information]
• Louie, E., Morley, K., Giannopoulos, V., Uribe Guajardo, M., Wood, K., Marel, C., Mills, K., Teesson, M., Edwards, M., Childs, S., Baillie, A., Haber, P., et al (2021). Implementation of a Multi-Modal Training Program for the Management of Comorbid Mental Disorders in Drug and Alcohol Settings: Pathways to Comorbidity Care (PCC). Journal of Dual Diagnosis, 17(4), 304-312. [More Information]
• Morley, K., Perry, C., Watt, J., Hurzeler, T., Leggio, L., Lawrence, A., Haber, P. (2021). New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies. Expert Opinion on Pharmacotherapy, 22(10), 1291-1303. [More Information]
• Haber, P., Riordan, B., Day, C., Monds, L., Baillie, A., Reid, S., Mills, K., Doyle, M., Teesson, M., Morley, K., Mooney-Somers, J., Lintzeris, N., Stapinski, L., Marel, C., Conigrave, K., Winter, D. (2021). New Australian guidelines for the treatment of alcohol problems: an overview of recommendations. Medical Journal of Australia, 215(Suppl 7), S3-S32. [More Information]
• Crouse, J., Morley, K., Buckley, N., Dawson, A., Seth, D., Monds, L., Tickell (nee Kennedy), A., Kay-Lambkin, F., Chitty, K. (2021). Online interventions for people hospitalized for deliberate self-harm and problematic alcohol use: Lessons learned from the iiAIM trial. Bulletin of the Menninger Clinic, 85(2), 123-142. [More Information]
• Hurzeler, T., Giannopoulos, V., Uribe, G., Louie, E., Haber, P., Morley, K. (2021). Psychosocial Interventions for Reducing Suicidal Behaviour and Alcohol Consumption in Patients With Alcohol Problems: A Systematic Review of Randomized Controlled Trials. Alcohol and Alcoholism, 56(1), 17-27. [More Information]
• Giannopoulos, V., Morley, K., Uribe, G., Louie, E., Wood, K., Teesson, M., Baillie, A., Haber, P. (2021). The role of clinical supervision in implementing evidence-based practice for managing comorbidity. The Clinical Supervisor, 40(1), 158-177. [More Information]
• Haber, P., Riordan, B., Morley, K. (2021). Treatment of alcohol problems: current status and future directions. Medical Journal of Australia, 215(7), 315-316. [More Information]
• Riordan, B., Winter, D., Haber, P., Day, C., Morley, K. (2021). What are people saying on social networking sites about the Australian alcohol consumption guidelines? Medical Journal of Australia, 214(3), 105-1.07E+03. [More Information]

2020

• Adams, C., Conigrave, J., Lewohl, J., Haber, P., Morley, K. (2020). Alcohol use disorder and circulating cytokines: A systematic review and meta-analysis. Brain, Behavior, and Immunity, 89, 501-512. [More Information]
• Logberger, W., Baillie, A., Haber, P., Morley, K. (2020). Baclofen modulates cardiovascular responses to appetitive cues in treatment-seeking alcohol use disorder individuals. Human Psychopharmacology-Clinical and Experimental, 35(2), e2722. [More Information]
• Morley, K., Lagopoulos, J., Logberger, W., Baillie, A., Adams, C., Haber, P. (2020). Brain GABA levels are reduced in alcoholic liver disease: A proton magnetic resonance spectroscopy study. Addiction Biology, 25(1), e12702. [More Information]
• Morley, K., Lagopoulos, J., Logberger, W., Chitty, K., Moustafa, A., Haber, P. (2020). Brain N-Acetyl Aspartate and associations with cognitive impairment in alcohol dependent patients. Journal of Clinical and Experimental Neuropsychology, 42(2), 111-117. [More Information]
• Conigrave, J., Lee, K., Zheng, C., Wilson, S., Perry, J., Chikritzhs, T., Slade, T., Morley, K., Room, R., Callinan, S., Conigrave, K., et al (2020). Drinking risk varies within and between Australian Aboriginal and Torres Strait Islander samples: a meta-analysis to identify sources of heterogeneity. Addiction, 115(10), 1817-1830. [More Information]
• Rombouts, S., Conigrave, J., Saitz, R., Louie, E., Haber, P., Morley, K. (2020). Evidence based models of care for the treatment of alcohol use disorder in primary health care settings: a systematic review. BMC Family Practice, 21(1), 260. [More Information]
• Chung, P., Logberger, W., Riordan, B., Haber, P., Merriman, M., Phipps-Green, A., Topless, R., Merriman, T., Conner, T., Morley, K. (2020). Genetic Polymorphisms on OPRM1, DRD2, DRD4, and COMT in Young Adults: Lack of Association With Alcohol Consumption. Frontiers in Psychiatry, 11, 1-6. [More Information]
• Louie, E., Barrett, E., Baillie, A., Haber, P., Morley, K. (2020). Implementation of evidence-based practice for alcohol and substance use disorders: protocol for systematic review. Systematic Reviews, 9(1), 25. [More Information]
• Wood, K., Giannopoulos, V., Louie, E., Baillie, A., Uribe, G., Lee, K., Haber, P., Morley, K. (2020). The role of clinical champions in facilitating the use of evidence-based practice in drug and alcohol and mental health settings: A systematic review. Implementation Research and Practice, 1(Jan-Dec), 1-11. [More Information]

2019

• Sheynin, J., Myers, C., Ghafar, F., Morris, A., Morley, K., Haber, P., Moustafa, A. (2019). A pilot study of escape, avoidance, and approach behaviors in treated alcohol-dependent males. Journal of Clinical and Experimental Neuropsychology, 41(6), 601-614. [More Information]
• Jamshidi, N., Morley, K., Cairns, R., Dawson, A., Haber, P. (2019). A Review of Baclofen Overdoses in Australia: Calls to a Poisons Information Centre and a Case Series. Alcohol and Alcoholism, 54(1), 73-78. [More Information]
• Rombouts, S., Baillie, A., Haber, P., Morley, K. (2019). Clinical Predictors of Response to Baclofen in the Treatment of Alcohol use Disorder: Results from the BacALD Trial. Alcohol and Alcoholism, 54(3), 272-278. [More Information]
• Byrne, S., Haber, P., Baillie, A., Giannopolous, V., Morley, K. (2019). Cue Exposure Therapy for Alcohol Use Disorders: What Can Be Learned from Exposure Therapy for Anxiety Disorders? Substance Use and Misuse, 54(12), 2053-2063. [More Information]
• Rombouts, S., Conigrave, J., Louie, E., Haber, P., Morley, K. (2019). Evidence-based models of care for the treatment of alcohol use disorder in primary health care settings: Protocol for systematic review. Systematic Reviews, 8(1), 1-6. [More Information]
• Logge, W., Morley, K., Haber, P., Baillie, A. (2019). Executive Functioning Moderates Responses to Appetitive Cues: A Study in Severe Alcohol Use Disorder and Alcoholic Liver Disease. Alcohol and Alcoholism, 54(1), 38-46. [More Information]
• Hallinan, R., Elsayed, M., Espinoza, D., Veillard, A., Morley, K., Lintzeris, N., Haber, P. (2019). Insomnia and excessive daytime sleepiness in women and men receiving methadone and buprenorphine maintenance treatment. Substance Use and Misuse, 54(10), 1589-1598. [More Information]
• Sibanda, N., Kornhaber, R., Hunt, G., Morley, K., Cleary, M. (2019). Prevalence and Risk Factors of Emergency Department Presentations with Methamphetamine Intoxication or Dependence: A Systematic Review and Meta-analysis. Issues in Mental Health Nursing, 40(7), 567-578. [More Information]
• Hunt, G., Siegfried, N., Morley, K., Brooke-Sumner, C., Cleary, M. (2019). Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews, 2019 (12), 1-228. [More Information]
• Byrne, S., Haber, P., Baillie, A., Costa, D., Fogliati, V., Morley, K. (2019). Systematic Reviews of Mindfulness and Acceptance and Commitment Therapy for Alcohol Use Disorder: Should we be using Third Wave Therapies? Alcohol and Alcoholism, 54(2), 159-166. [More Information]
• Louie, E., Giannopoulos, V., Baillie, A., Uribe Guajardo, M., Byrne, S., Deady, M., Teesson, M., Baker, A., Haber, P., Morley, K. (2019). Translating Evidence-Based Practice for Managing Comorbid Substance Use and Mental Illness Using a Multimodal Training Package. Journal of Dual Diagnosis, 14(2), 111-119. [More Information]

2018

• Agabio, R., Sinclair, J., Addolorato, G., Aubin, H., Beraha, E., Caputo, F., Chick, J., de La Selle, P., Franchitto, N., Haber, P., Morley, K., et al (2018). Baclofen for the treatment of alcohol use disorder: the Cagliari Statement. The Lancet Psychiatry, 5(12), 957-960. [More Information]
• Morley, K., Baillie, A., Fraser, I., Furneaux-Bate, A., Dore, G., Roberts, M., Abdalla, A., Phung, N., Haber, P. (2018). Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial. British Journal of Psychiatry, 212(6), 362-369. [More Information]
• Heng, S., Jamshidi, N., Baillie, A., Louie, E., Dore, G., Phung, N., Haber, P., Morley, K. (2018). Baclofen Response in Alcohol Dependent Patients Concurrently Receiving Antidepressants: Secondary Analysis From the BacALD Study. Frontiers in Psychiatry, 9(576), 1-7. [More Information]
• Scherbaum, S., Haber, P., Morley, K., Underhill, D., Moustafa, A. (2018). Biased and less sensitive: A gamified approach to delay discounting in heroin addiction. Journal of Clinical and Experimental Neuropsychology, 40(2), 139-150. [More Information]
• Morley, K., Sitharthan, G., Haber, P., Tucker, P., Sitharthan, T. (2018). Characteristics of suicide attempters and ideators in a clinical sample of substance users. Substance Use and Misuse, 53(11), 1811-1818. [More Information]
• Pierce, M., Sutterland, A., Beraha, E., Morley, K., van den Brink, W. (2018). Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: A systematic review and meta-analysis. European Neuropsychopharmacology, 28(7), 795-806. [More Information]
• Radell, M., Allen, M., Favaloro, B., Myers, C., Haber, P., Morley, K., Moustafa, A. (2018). Intolerance of uncertainty and conditioned place preference in opioid addiction. PeerJ, 6, e4775. [More Information]
• Conigrave, K., Ivers, R., Morley, K., Haber, P. (2018). Managing your withdrawal from alcohol at home. Medicine Today, 19(12), 33-34.
• Morley, K., Luquin, N., Baillie, A., Fraser, I., Trent, R., Dore, G., Phung, N., Haber, P. (2018). Moderation of baclofen response by a GABAB receptor polymorphism: Results from the BacALD randomized controlled trial. Addiction, 113(12), 2205-2213. [More Information]
• Morley, K., Baillie, A., van den Brink, W., Chitty, K., Brady, K., Back, S., Seth, D., Sutherland, G., Leggio, L., Haber, P. (2018). N-acetyl cysteine in the treatment of alcohol use disorder in patients with liver disease: Rationale for further research. Expert Opinion on Investigational Drugs, 27(8), 667-675. [More Information]
• Morley, K., Lagopoulos, J., Logberger, W., Chitty, K., Baillie, A., Haber, P. (2018). Neurometabolite levels in alcohol use disorder patients during baclofen treatment and prediction of relapse to heavy drinking. Frontiers in Psychiatry, 9(SEP), 1-8. [More Information]
• Stoklosa, T., Morley, K., Volovets, A., Haber, P. (2018). Pharmacotherapy for Alcohol Use Disorder in the Context of Liver Disease. Current Addiction Reports, 5(2), 287-296. [More Information]
• Faingold, A., Morley, K., White, B., Walker, E., Haber, P. (2018). Psychostimulant-related health service demand in an inner-city hospital, 2012-2015. Public Health Research and Practice, 28(1), 1-6. [More Information]
• de Beaurepaire, R., Sinclair, J., Heydtmann, M., Addolorato, G., Aubin, H., Beraha, E., Caputo, F., Chick, J., de La Selle, P., Franchitto, N., Haber, P., Morley, K., et al (2018). The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective. Frontiers in Psychiatry, 9, 1-16. [More Information]
• Morley, K., Kranzler, H., Luquin, N., Baillie, A., Shanahan, M., Trent, R., Teesson, M., Haber, P. (2018). Topiramate versus naltrexone for alcohol use disorder: Study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study). Trials, 19(1), 1-10. [More Information]
• Conigrave, K., Ivers, R., Morley, K., Haber, P. (2018). Treating alcohol dependence: Managing withdrawal and preventing relapse. Medicine Today, 19(12), 24-32.

2017

• Larsen, M., Shand, F., Morley, K., Batterham, P., Petrie, K., Reda, B., Berrouiguet, S., Haber, P., Carter, G., Christensen, H. (2017). A Mobile Text Message Intervention to Reduce Repeat Suicidal Episodes: Design and Development of Reconnecting After a Suicide Attempt (RAFT). JMIR Mental Health, 4(4), 1-9. [More Information]
• Myers, C., Rego, J., Haber, P., Morley, K., Beck, K., Hogarth, L., Moustafa, A. (2017). Learning and generalization from reward and punishment in opioid addiction. Behavioural Brain Research, 317, 122-131. [More Information]
• Morley, K., Cornish, J., Faingold, A., Wood, K., Haber, P. (2017). Pharmacotherapeutic agents in the treatment of methamphetamine dependence. Expert Opinion on Investigational Drugs, 26(5), 563-578. [More Information]
• Mahlberg, J., Haber, P., Morley, K., Weidemann, G., Hogarth, L., Beck, K., Myers, C., Moustafa, A. (2017). Reward and punishment-based compound cue learning and generalization in opiate dependency. Experimental Brain Research, 235(10), 3153-3162. [More Information]
• Morley, K., Logge, W., Pearson, S., Baillie, A., Haber, P. (2017). Socioeconomic and geographic disparities in access to pharmacotherapy for alcohol dependence. Journal of Substance Abuse Treatment, 74, 23-25. [More Information]

2016

• Freyer, C., Morley, K., Haber, P. (2016). Alcohol use disorders in Australia. Internal Medicine Journal, 46(11), 1259-1268. [More Information]
• Morley, K., Baillie, A., Leung, S., Sannibale, C., Teesson, M., Haber, P. (2016). Is Specialized Integrated Treatment for Comorbid Anxiety, Depression and Alcohol Dependence Better than Treatment as Usual in a Public Hospital Setting? Alcohol and Alcoholism, 51(4), 402-409. [More Information]
• Morley, K., Logge, W., Pearson, S., Baillie, A., Haber, P. (2016). National trends in alcohol pharmacotherapy: findings from an Australian claims database. Drug and Alcohol Dependence, 166, 254-257. [More Information]
• Haber, P., Morley, K. (2016). The impact of alcohol pharmacotherapies on public health in Australia is limited by low prescribing rates. Public Health Research and Practice, 26(4), 1-4. [More Information]

2014

• Morley, K., Baillie, A., Leung, S., Addolorato, G., Leggio, L., Haber, P. (2014). Baclofen for the Treatment of Alcohol Dependence and Possible Role of Comorbid Anxiety. Alcohol and Alcoholism, 49(6), 654-660. [More Information]
• Hunt, G., Siegfried, N., Morley, K., Sitharthan, T., Cleary, M. (2014). Psychosocial interventions for people with both severe mental illness and substance misuse. Schizophrenia Bulletin, 40(1), 18-20. [More Information]
• Morley, K., Sitharthan, G., Haber, P., Tucker, P., Sitharthan, T. (2014). The Efficacy of an Opportunistic Cognitive Behavioral Intervention Package (OCB) on Substance Use and Comorbid Suicide Risk: A Multisite Randomized Controlled Trial. Journal of Consulting and Clinical Psychology, 82(1), 130-140. [More Information]

2013

• Morley, K., Baillie, A., Sannibale, C., Teesson, M., Haber, P. (2013). Integrated care for comorbid alcohol dependence and anxiety and/or depressive disorder: study protocol for an assessor-blind, randomized controlled trial. Addiction Science & Clinical Practice, 8, 1-8. [More Information]
• Hunt, G., Siegfried, N., Morley, K., Sitharthan, T., Cleary, M. (2013). Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews, 2013 (10), 1-258. [More Information]
• Morley, K., Leung, S., Baillie, A., Haber, P. (2013). The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): Study protocol for a randomised controlled trial. Contemporary Clinical Trials, 36(2), 348-355. [More Information]

2012

• Morley, K., Haber, P., Sitharthan, G., Tucker, P., Sitharthan, T. (2012). Clinical Predictors of Suicidal Behaviour Among Patients with Alcohol and/or Substance Abuse and Suicide Risk. APSAD Conference, Australasian Professional Society on Alcohol and other Drugs, Melbourne.
• Morley, K., Haber, P., Morgan, M., Samara, F. (2012). Pericyazine in the treatment of cannabis dependence in general practice: a naturalistic pilot trial. Substance Abuse and Rehabilitation, 3, 43-47. [More Information]

2010

• Morley, K., Teesson, M., Sannibale, C., Baillie, A., Haber, P. (2010). Clinical Predictors of Outcome from an Australian Pharmacological Relapse Prevention Trial. Alcohol and Alcoholism, 45, 520-526. [More Information]
• Baillie, A., Stapinski, L., Crome, E., Morley, K., Sannibale, C., Haber, P., Teesson, M. (2010). Some new directions for research on psychological interventions for comorbid anxiety and substance use disorders. Drug and Alcohol Review, 29(5), 518-524. [More Information]

2009

• Colagiuri, B., Morley, K., Boakes, R., Haber, P. (2009). Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence. Psychotherapy and Psychosomatics, 78(3), 167-171. [More Information]
• Haber, P., Lintzeris, N., Morley, K. (2009). Pharmacotherapies for alcohol dependence. In Paul Haber, Elizabeth Proude, Nick Lintzeris & Olga Lopatko (Eds.), Guidelines for the Treatment of Alcohol Problems, (pp. 93-106). Australia: Commonwealth of Australia.
• Morley, K., Teesson, M., Sannibale, C., Haber, P. (2009). Sample bias from different recruitment strategies in a randomised controlled trial for alcohol dependence. Drug and Alcohol Review, 28(3), 222-229. [More Information]

2008

• Richardson, K., Baillie, A., Reid, S., Morley, K., Teesson, M., Sannibale, C., Weltman, M., Haber, P. (2008). Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol? Addiction, 103(6), 953-959. [More Information]
• Thomson, C., Morley, K., Teesson, M., Sannibale, C., Haber, P. (2008). Issues with recruitment to randomised controlled trials in the drug and alcohol field: a literature review and Australian case study. Drug and Alcohol Review, 27(2), 115-122. [More Information]

2006

• Richardson, K., Reid, S., Morley, K., Teesson, M., Sannibale, C., Weltman, M., Baillie, A., Haber, P. (2006). The effects of alcohol and naltrexone on craving and alcohol consumption. Alcoholism: Clinical and Experimental Research, 30(s2), 169A-169A.
• Teesson, M., Morley, K., Reid, S., Sannibale, C., Thomson, C., Richardson, K., Haber, P. (2006). The influence of depression on pharmacotherapy for alcohol dependence. Alcoholism: Clinical and Experimental Research, 30(s2), 68A-68A.

2005

• Morley, K., Arnold, J., McGregor, I. (2005). Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29(5), 648-657. [More Information]

2004

• Morley, K., Li, K., Hunt, G., Mallet, P., McGregor, I. (2004). Cannabinoids Prevent The Acute Hyperthermia And Partially Protect Against The 5-Ht Depleting Effects Of Mdma ('Ecstasy') In Rats. Neuropharmacology, 46(7), 954-965. [More Information]
• Morley, K., Cornish, J., Li, K., McGregor, I. (2004). Preexposure To Mdma ("Ecstasy") Delays Acquisition But Facilitates Mdma-Induced Reinstatement Of Amphetamine Self-Administration Behavior In Rats. Pharmacology, Biochemistry and Behavior, 79(2), 331-342. [More Information]

2003

• Cornish, J., Shahnawaz, Z., Thompson, M., Wong, S., Morley, K., Hunt, G., McGregor, I. (2003). Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats. European Journal of Pharmacology, 482(1-3), 339-341. [More Information]
• McGregor, I., Gurtman, C., Morley, K., Clemens, K., Li, K., Blokland, A., Cornish, J., Hunt, G. (2003). Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes. Psychopharmacology, 168(4), 465-474. [More Information]
• Gallate, J., Morley, K., Ambermoon, P., McGregor, I. (2003). The consequences of beer consumption in rats: acute anxiolytic and ataxic effects and withdrawal-induced anxiety. Psychopharmacology, 166(1), 51-60. [More Information]

2002

• Gurtman, C., Morley, K., Li, K., Hunt, G., McGregor, I. (2002). Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion. European Journal of Pharmacology, 446(1-3), 89-96. [More Information]

2001

• Morley, K., Gallate, J., Hunt, G., McGregor, I., Mallet, P. (2001). Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("Ecstasy"). European Journal of Pharmacology, 433(1), 91-99. [More Information]